Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Idiopathic erythrocytosis: a germline disease?
Elli EM, Mauri M, D'Aliberti D, Crespiatico I, Fontana D, Redaelli S, Pelucchi S, Spinelli S, Manghisi B, Cavalca F, Aroldi A, Ripamonti A, Ferrari S, Palamini S, Mottadelli F, Massimino L, Ramazzotti D, Cazzaniga G, Piperno A, Gambacorti-Passerini C, Piazza R. Elli EM, et al. Clin Exp Med. 2024 Jan 20;24(1):11. doi: 10.1007/s10238-023-01283-y. Clin Exp Med. 2024. PMID: 38244120 Free PMC article.
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype.
Civettini I, Zappaterra A, Corti P, Messina A, Aroldi A, Biondi A, Cavalca F, Crippa V, Crosti F, Ferrari GM, Malighetti F, Mologni L, Piperno A, Ramazzotti D, Scollo C, Zambon A, Rossi F, Gambacorti-Passerini C. Civettini I, et al. Among authors: gambacorti passerini c. Med. 2024 Dec 18:100554. doi: 10.1016/j.medj.2024.11.007. Online ahead of print. Med. 2024. PMID: 39701095
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
Gambacorti-Passerini C, Piazza R. Gambacorti-Passerini C, et al. N Engl J Med. 2024 Dec 12;391(23):2274-2275. doi: 10.1056/NEJMc2412813. N Engl J Med. 2024. PMID: 39665662 No abstract available.
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients.
Malighetti F, Arosio G, Manfroni C, Mauri M, Villa M, Manghisi B, Inzoli E, Rindone G, Zambrotta GPM, Civettini I, Guglielmana V, Ramazzotti D, Giudici G, Bombelli S, Perego R, Piazza R, Mologni L, Gambacorti-Passerini C. Malighetti F, et al. Hemasphere. 2023 Feb 24;7(3):e852. doi: 10.1097/HS9.0000000000000852. eCollection 2023 Mar. Hemasphere. 2023. PMID: 36860269 Free PMC article. No abstract available.
Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients With Lymphoproliferative Disorders on BTKi.
Zamprogna G, Frustaci AM, Travi G, Borella C, Reda G, Motta M, Deodato M, Bossi E, Mattiello V, Ferrari MB, Cotilli G, Gambacorti-Passerini C, Cairoli R, Puoti M, Tedeschi A. Zamprogna G, et al. Hemasphere. 2023 May 4;7(5):e880. doi: 10.1097/HS9.0000000000000880. eCollection 2023 May. Hemasphere. 2023. PMID: 37153871 Free PMC article. No abstract available.
Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients.
Zappaterra A, Civettini I, Cafro AM, Pezzetti L, Pierini S, Anghilieri M, Bellio L, Bertazzoni P, Grillo G, Minga P, Pioltelli ML, Ravano E, Sassone M, Viganò CV, Volpato EB, Gambacorti-Passerini C, Rossini S, Cairoli R, Crocchiolo R. Zappaterra A, et al. Blood Transfus. 2024 Jul;22(4):328-337. doi: 10.2450/BloodTransfus.667. Blood Transfus. 2024. PMID: 38315530 Free PMC article.
374 results